This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Aristocrat Technologies, Inc., Institute of Bioorganic Chemistry. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2026
Title: Innovations by Inventor Marta Olejniczak
Introduction
Marta Olejniczak, an accomplished inventor based in Poznan, Poland, has made significant contributions to the field of biotechnology. With a focus on developing new therapeutic methods, she holds two patents that showcase her innovative approaches to treating neurological diseases.
Latest Patents
Olejniczak's most recent patents include a nucleic acid molecule, an expression cassette, an expression vector, and a method of inducing RNA interference in eukaryotic host cells. These inventions are pivotal in the therapeutic landscape, particularly for conditions induced by the expansion of trinucleotide CAG repeats, known to be linked with hereditary human neurological diseases. The innovative solution she brings forward employs RNA interference technology, aiming to mitigate the effects of these genetic disorders.
Career Highlights
Throughout her career at the Institute of Bioorganic Chemistry, Marta has focused her research on genetic therapies and molecular biology. Her dedication has led to breakthroughs that could change the way neurological conditions related to CAG repeat expansions are treated. The implications of her work may provide hope for many patients suffering from these hereditary diseases.
Collaborations
Marta collaborates closely with notable colleagues, including Wlodzimierz Krzyzosiak and Paulina Galka-Marciniak. Together, they explore innovative solutions and advance the research in biotechnology, fostering an environment of creativity and scientific inquiry.
Conclusion
Marta Olejniczak's innovative work is redefining the treatments available for hereditary neurological diseases. Her patents reflect a commitment to harnessing cutting-edge technology and scientific understanding to develop therapeutic solutions. As she continues to push the boundaries of research, her contributions will undoubtedly pave the way for new advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile